MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada
4 Articles
4 Articles
A one-time Ottawa program — launched on the sidelines of the 24th International AIDS Conference in Montreal in the summer of 2022 — allowed the purchase and distribution of self-test kits for HIV until March 2024. Since then, and although testing has been under provincial jurisdiction, Quebec has not taken over the torch and the community has now been sounding alarms at empty self-test stocks for months.


MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada
HALIFAX, NS / ACCESS Newswire / July 7, 2025 / MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has officially started earlier than anticipated to evaluate MedMira's Multiplo® TP/HIV rapid test for use…
MedMira launches clinical trial for Multiplo TP/HIV self-test in Canada - BioTuesdays
MedMira (TSXV: MIR) has announced the launch of a clinical trial to evaluate its Multiplo TP/HIV rapid test for use as a self-test in Canada. Multiplo is a dual HIV and syphilis rapid self-test that delivers immediate results from a simple finger-prick blood sample. The first participants have now been enrolled at the Cool Aid Community Health Centre in Victoria, British Columbia and at Women’s Health In Women’s Hands Community Health Clinic in …
Coverage Details
Bias Distribution
- 67% of the sources lean Left
To view factuality data please Upgrade to Premium